GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hanmi Pharm Co Ltd (XKRX:128940) » Definitions » 14-Day RSI

Hanmi Pharm Co (XKRX:128940) 14-Day RSI : 41.48 (As of Mar. 25, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Hanmi Pharm Co 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2025-03-25), Hanmi Pharm Co's 14-Day RSI is 41.48.

The industry rank for Hanmi Pharm Co's 14-Day RSI or its related term are showing as below:

XKRX:128940's 14-Day RSI is ranked better than
76.48% of 1084 companies
in the Drug Manufacturers industry
Industry Median: 47.975 vs XKRX:128940: 41.48

Competitive Comparison of Hanmi Pharm Co's 14-Day RSI

For the Drug Manufacturers - Specialty & Generic subindustry, Hanmi Pharm Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hanmi Pharm Co's 14-Day RSI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hanmi Pharm Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Hanmi Pharm Co's 14-Day RSI falls into.



Hanmi Pharm Co  (XKRX:128940) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hanmi Pharm Co  (XKRX:128940) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Hanmi Pharm Co 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Hanmi Pharm Co's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Hanmi Pharm Co Business Description

Traded in Other Exchanges
N/A
Address
45 Bangi-dong, Songpa, Seoul, Gyeonggi, KOR, 138-724
Hanmi Pharm Co Ltd is a Korea-based company, engaged in manufacturing and marketing of medicines, medical supplies and raw materials for medicines. The company makes strenuous and enthusiastic efforts to develop treatments for diabetes, obesity, cancer, autoimmune and rare disease to keep everyone's health and improve their quality of life. The group distributes its products within Korean market and to overseas markets.

Hanmi Pharm Co Headlines

No Headlines